MEADE HARRY 4
4 · GTC BIOTHERAPEUTICS INC · Filed Apr 1, 2009
Insider Transaction Report
Form 4
MEADE HARRY
SVP, Transgenic Research
Transactions
- Award
Stock Option (Right to Buy)
2009-03-30+35,000→ 35,000 totalExercise: $0.37Exp: 2019-03-30→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]20% of the option vested on March 30, 2009. The remaining 80% will vest in four equal annual installments on each of March 30, 2010, 2011, 2012 and 2013.